Wed, Nov 24, 10:21 AM, Zacks
Biotech Stock Roundup: Drug Approvals for BMRN, Updates From BIIB, BMY, MRNA & More
Drug approvals for BioMarin (BMRN) and regulatory updates from Biogen (BIIB), among others, have been the biotech sector's few key highlights during the past week.
Wed, Nov 24, 7:46 AM, Zacks
Bristol Myers (BMY) Zeposia Gets EC Nod for Ulcerative Colitis
Bristol Myers (BMY) wins EC approval for Zeposia for a second indication ??? ulcerative colitis.